Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Creams: SOP for Ensuring Data Integrity in QC Documentation – V 2.0

Posted on By

Creams: SOP for Ensuring Data Integrity in QC Documentation – V 2.0

Standard Operating Procedure for Ensuring Data Integrity in QC Documentation

Department Creams
SOP No. SOP/CRM/154/2025
Supersedes SOP/CRM/154/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to establish a procedure for ensuring the integrity of data documented in the QC laboratory during the testing of cream formulations. Data integrity is essential to ensure that all records are accurate, consistent, and trustworthy, meeting the standards required for regulatory compliance and quality assurance.

2. Scope

This SOP applies to all QC documentation related to the testing of cream formulations, including testing logs, calibration records, and performance data. It covers the procedures to ensure that data is accurately recorded, securely stored, and readily retrievable for review and audit purposes.

3. Responsibilities

  • Quality Control (QC) Team: Responsible for accurately documenting test results, calibrations, and equipment performance data. QC staff must ensure that all data entries are legible, complete, and free from errors.
  • Quality Assurance (QA) Team: Responsible for reviewing the data documentation for completeness and compliance with internal and regulatory standards. QA will also ensure that proper data retention practices are
followed.
  • IT/Systems Team: Responsible for ensuring that electronic data systems are secure, validated, and compliant with regulatory requirements, including backup and retrieval procedures for electronic data.
  • 4. Accountability

    The QC Manager is accountable for ensuring that data integrity is maintained in all QC documentation. The QA Manager is responsible for reviewing and ensuring that data integrity standards are met and compliance is maintained. The IT/Systems Team is responsible for the security and validation of electronic data systems.

    5. Procedure

    5.1 Data Entry and Recording

    1. Ensure that all test results, calibration data, and equipment performance data are accurately recorded in the appropriate forms, logbooks, or electronic systems.
    2. For manual entries, use clear and legible handwriting. For electronic records, ensure that the data is input correctly and consistently. Avoid using abbreviations that may lead to confusion.
    3. Ensure that all entries are made in real-time as the test is being performed, and do not leave blank spaces on forms. If there is a need to add information later, draw a single line through the space, and record the additional information with the current date and signature.

    5.2 Correction of Errors

    1. If an error is found in the documentation, it should be corrected immediately in accordance with established procedures. The incorrect entry should be crossed out with a single line (not erased or obliterated), and the corrected information should be entered next to it with the date, time, and signature of the person making the correction.
    2. In electronic records, ensure that changes are tracked using the system’s audit trail feature, with a reason for the change noted and authorized by the appropriate personnel.
    3. Ensure that all corrections comply with Good Documentation Practices (GDP) and that all changes are transparent and traceable to ensure data integrity.

    5.3 Data Security and Storage

    1. Ensure that all data, both paper-based and electronic, is securely stored and protected from unauthorized access. Paper records should be stored in locked cabinets or rooms, and electronic data should be stored in validated systems with password protection and access control.
    2. Ensure that all data is backed up regularly, with both on-site and off-site backup options available for critical data. Backup systems should be tested periodically to ensure that data can be restored as needed.
    3. For electronic data, ensure that the data management system has features such as data encryption, automatic logging of changes, and secure audit trails to preserve data integrity and meet regulatory requirements.

    5.4 Data Retention and Retrieval

    1. Ensure that all QC documentation is retained for the required duration according to regulatory and internal policies (typically a minimum of two years or as per regulatory requirements).
    2. Ensure that documents are readily retrievable in the event of an audit or inspection. This includes maintaining organized filing systems for paper records and ensuring electronic data is stored in easily accessible formats.
    3. Perform periodic reviews to ensure that the data retention and retrieval systems are working as intended and that records are not lost or damaged over time.

    5.5 Audit and Review of Data Integrity

    1. Conduct regular internal audits to assess compliance with data integrity standards and identify potential weaknesses in the data documentation process. Document the audit results and take corrective actions where necessary.
    2. The QA team should review the results of these audits, along with the relevant documentation, to ensure that the data integrity standards are being adhered to across the organization.

    5.6 Documentation and Record-Keeping

    1. Ensure that all records related to data integrity (e.g., audit logs, data correction logs, backup records) are complete, accurate, and securely stored in compliance with regulatory and internal requirements.
    2. Ensure that data entry, correction, storage, and retrieval procedures are regularly reviewed and updated to remain compliant with current regulations and best practices.
    3. Maintain a log of any deviations from data integrity protocols and the corrective actions taken to resolve them. Document these deviations in the Deviation Log (Annexure-1).

    6. Abbreviations

    • GMP: Good Manufacturing Practices
    • QC: Quality Control
    • QA: Quality Assurance
    • PPE: Personal Protective Equipment
    • GDP: Good Documentation Practices

    7. Documents

    1. Annexure-1: Deviation Log
    2. Annexure-2: Data Integrity Audit Log

    8. References

    • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
    • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • FDA Guidance for Industry: Data Integrity and Compliance with CGMP

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Deviation Log

    Deviation Date Deviation Description Corrective Action Taken Operator
    21/01/2026 Missing entry in data log Corrected and re-entered data in system John Doe

    Annexure-2: Data Integrity Audit Log

    Audit Date Audit Findings Corrective Action Taken Audit By
    21/01/2026 No discrepancies found None Jane Smith

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/03/2024 1.0 Initial Version New SOP Creation QA Head
    01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
    See also  Creams: SOP for Conducting Heavy Metal Testing in Creams - V 2.0
    Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

    Post navigation

    Previous Post: BA-BE Studies: SOP for Ensuring Study Staff Role Clarity – V 2.0
    Next Post: API Manufacturing: SOP for Stability Testing of API Batches – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version